Table 2.
Correlation matrix between IRS ERα, IRS SST2, FSH (%), LH (%), age and diameter in all, male and female cases.
| Clinicopathological Characteristics | IRS SST2 | FSH (%) | LH (%) | Age (years) | Diameter (mm) |
|---|---|---|---|---|---|
| Spearman’s Rho/Adjusted p-Value (Holm’s Method)/n | |||||
| IRS ERα | |||||
| All | 0.44/<0.0001/97 | 0.40/0.0005/98 | −0.05/1/98 | 0.06/1/98 | 0.04/1/98 |
| Males | 0.51/0.0002/64 | 0.31/0.16/64 | 0.01/1/64 | 0.11/1/64 | 0.04/1/64 |
| Females | 0.32/0.83/33 | 0.58/0.004/34 | −0.16/1/34 | −0.006/1/34 | 0.13/1/34 |
| IRS SST2 | |||||
| All | 0.23/0.24/97 | −0.13/1/97 | 0.23/0.26/98 | −0.19/0.65/98 | |
| Males | 0.18/1/64 | −0.02/1/64 | 0.29/0.24/64 | −0.28/0.29/64 | |
| Females | 0.32/0.82/33 | −0.36/0.55/33 | 0.10/1/33 | 0.03/1/33 | |
| FSH (%) | |||||
| All | −0.04/1/98 | 0.13/1/98 | 0.02/1/98 | ||
| Males | 0.10/1/64 | 0.18/1/64 | 0.04/1/64 | ||
| Females | −0.30/0.92/34 | 0.05/1/34 | 0.07/1/34 | ||
| LH (%) | |||||
| All | 0.17/0.90/98 | 0.08/1/98 | |||
| Males | 0.13/1/64 | −0.01/1/64 | |||
| Females | 0.18/1/34 | 0.02/1/34 | |||
| Age (years) | |||||
| All | −0.03/1/98 | ||||
| Males | −0.12/1/64 | ||||
| Females | 0.12/1/34 | ||||
Abbreviations: immunoreactive score (IRS), estrogen receptor alpha (ERα), somatostatin receptor 2 (SST2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), number of patients for which the data is available (n).